Common Variable Immune Deficiency Disorders ( CVID ) in the Indigenous Māori of Aotearoa (New Zealand) Are Associated With a High Prevalence of Bronchiectasis and Complete IgA Deficiency
Scandinavian Journal of Immunology · 2025
DOI: 10.1111/sji.70068 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2025. Verfasst von Rohan Ameratunga und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Immunology, Auckland City Hospital, Auckland, New Zealand. Hauptthemen laut MEDLINE: Bronchiectasis, Common Variable Immunodeficiency, IgA Deficiency. Die Arbeit nennt 58 Literaturangaben.
Abstract (Originalsprache)
The New Zealand (NZ) Common Variable Immunodeficiency Disorders (CVID) study (NZCS) is a long‐term prospective cohort study, which seeks to better understand the proximal causes and sequelae of CVID. Patients were accepted to the NZCS if they had a diagnosis of CVID. After informed consent, clinical and demographic data were obtained by an interviewer‐assisted questionnaire. Computerised case notes and laboratory results, linked to each patient's National Health Index (NHI) number, were also reviewed. In the current analysis, ethnic‐specific data was obtained on the prevalence of CVID and its sequelae in NZ. One hundred and eight patients with a diagnosis of CVID were enrolled in the NZCS, comprising approximately 70% of patients known to have CVID in NZ. There was a much greater prevalence of bronchiectasis in Māori (79%) compared to Caucasian CVID patients (38%). Māori patients with CVID develop symptoms at a younger age and have an increased number of severe infections prior to diagnosis. Māori CVID patients with bronchiectasis had a higher prevalence of complete IgA deficiency compared to Caucasian CVID patients with bronchiectasis. In contrast to Caucasian patients with CVID, autoimmune and inflammatory sequelae were much less common in Māori. This study also demonstrated worsening diagnostic delays in patients with CVID in NZ. The Indigenous Māori of Aotearoa have a much more aggresssive early‐onset, infection‐only CVID variant compared to Caucasian New Zealanders.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Clinical Immunology, Auckland City Hospital, Auckland, New Zealand.
- Department of Virology and Immunology, Auckland City Hospital, Auckland, New Zealand.
- Department of Molecular Medicine and Pathology, University of Auckland, Auckland, New Zealand.
- Department of Respiratory Medicine, Starship Hospital, Auckland, New Zealand.
- Department of Paediatrics Child and Youth Health, Faculty of Medical and Health Sciences, University of Auckland, Auckland, New Zealand.
- Department of Clinical Immunology, Wellington Hospital, Wellington, New Zealand.
ORCID-Profile: Rohan Ameratunga
Zitieren
APA
Ameratunga, R., Byrnes, C. A., Jordan, A., Steele, R., Allan, C., Woon, S. T., & Brewerton, M. (2025). Common Variable Immune Deficiency Disorders ( CVID ) in the Indigenous Māori of Aotearoa (New Zealand) Are Associated With a High Prevalence of Bronchiectasis and Complete IgA Deficiency. Scandinavian Journal of Immunology. https://doi.org/10.1111/sji.70068
Vancouver
Ameratunga R, Byrnes CA, Jordan A, Steele R, Allan C, Woon ST, et al. Common Variable Immune Deficiency Disorders ( CVID ) in the Indigenous Māori of Aotearoa (New Zealand) Are Associated With a High Prevalence of Bronchiectasis and Complete IgA Deficiency. Scandinavian Journal of Immunology. 2025. doi:10.1111/sji.70068
BibTeX
@article{Ameratunga2025,
author = {Ameratunga, Rohan and Byrnes, Catherine A and Jordan, Anthony and Steele, Richard and Allan, Caroline and Woon, See-Tarn and Brewerton, Maia},
title = {Common Variable Immune Deficiency Disorders ( CVID ) in the Indigenous Māori of Aotearoa (New Zealand) Are Associated With a High Prevalence of Bronchiectasis and Complete IgA Deficiency},
journal = {Scandinavian Journal of Immunology},
year = {2025},
doi = {10.1111/sji.70068}
}
EUVIMED